Allison Luo, MD

Dr Allison Luo has over two decades of clinical development expertise in the biopharmaceutical industry, most recently serving as Chief Medical Officer of Prometheus Biosciences. Dr Luo was previously Chief Medical Officer of Escalier and Oppilan (Ventyx), Senior Vice President of Clinical Development for Gastroenterology at Progenity (Biora), and Vice President of Clinical Development at Ophthotech (Iveric Bio), where she successfully completed two Phase 3 studies. She also worked at Bristol Myers Squibb, overseeing programs for Orencia® and eldelumab. Dr Luo earned a BS in biochemistry and an MD from Northwestern University, followed by a fellowship in drug development at Abbott Laboratories (AbbVie).